| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 223.65B | 234.70B | 207.82B | 192.54B | 164.48B | 134.20B |
| Gross Profit | 126.46B | 133.05B | 116.26B | 106.28B | 90.22B | 74.31B |
| EBITDA | 28.87B | 30.33B | 26.18B | 20.87B | 17.86B | 9.01B |
| Net Income | 13.37B | 17.71B | 11.85B | 12.84B | 9.95B | 4.00B |
Balance Sheet | ||||||
| Total Assets | 160.56B | 164.50B | 148.82B | 127.66B | 113.08B | 93.92B |
| Cash, Cash Equivalents and Short-Term Investments | 90.54B | 96.26B | 85.72B | 67.23B | 63.84B | 52.25B |
| Total Debt | 12.82B | 13.19B | 14.74B | 12.85B | 12.97B | 12.95B |
| Total Liabilities | 83.21B | 78.33B | 75.46B | 64.21B | 57.89B | 46.53B |
| Stockholders Equity | 74.83B | 83.55B | 70.89B | 63.44B | 55.18B | 47.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 17.89B | 19.15B | 10.49B | 14.67B | 6.49B |
| Operating Cash Flow | 0.00 | 21.33B | 22.04B | 13.46B | 17.03B | 7.97B |
| Investing Cash Flow | 0.00 | -4.21B | 792.00M | -4.40B | -2.60B | -582.00M |
| Financing Cash Flow | 0.00 | -6.59B | -4.36B | -5.67B | -2.83B | -18.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥21.20T | 40.16 | 19.84% | 0.90% | 9.56% | 16.37% | |
73 Outperform | ¥754.25B | 20.92 | 8.48% | 2.02% | ― | ― | |
72 Outperform | ¥41.55B | -29.01 | ― | 3.62% | -0.98% | -29.86% | |
72 Outperform | ¥70.07B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
71 Outperform | ¥270.46B | 19.34 | ― | 1.46% | 12.02% | -15.70% | |
71 Outperform | ¥126.66B | 24.22 | 5.53% | 6.09% | -1.03% | 4.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |